Autologous bone marrow-derived mesenchymal stem cells therapy (Institute Of Field Blood Transfusion, Chinese Academy Of Military Medical Sciences)
自体骨髓间充质干细胞（中国人民解放军军事医学科学院野战输血研究所）
Report date: 2023/01/12 15:47:38
Base Information
Drug NameAutologous bone marrow-derived mesenchymal stem cells therapy (Institute Of Field Blood Transfusion, Chinese Academy Of Military Medical Sciences)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Field Blood Transfusion, Chinese Academy Of Military Medical Sciences
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesInstitute Of Field Blood Transfusion, Chinese Academy Of Military Medical Sciences
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A